SAN CARLOS, Calif.--Nov 10, 2025--CuraSen Therapeutics, Inc., a biopharmaceutical company developing drug candidates with broad applicability in neurodegenerative and neuropsychiatric diseases, today announced encouraging results from a Phase 1 study...
Three new companies spring to life from boron research at RTP-based Boragen
Research Triangle Park-based Boragen to be split into three different companies, one focused on crop protection, one on animal health, and the other on human health.
